Abstract PS10-27: A phase II proof-of-concept study of palbociclib (P) rechallenge in patients (pts) with hormone receptor (HR)[+]/HER2[-] metastatic breast cancer (MBC) and clinical benefit to prior P-based treatment (BIOPER)

Antonio Llombart-Cussac,Javier Cortés,Beatriz Bellosillo Paricio,Miguel Gil Gil,Giuseppe Curigliano,José Manuel Pérez-García,Laura Comerma Blesa,Manuel Ruíz Borrego,Enrique Espinosa,Lourdes Calvo,Begoña Bermejo,Meritxell Bellet,Federico Rojo Todo,Juan de la Haba,Vanesa Quiroga,Alessandro Minisini,Ana Santaballa,Miguel Sampayo,Andrea Malfettone,Joan Albanell

Cancer Research（2021）

Cited 0|Views10
No score
Key words
metastatic breast cancer,breast cancer,palbociclib,hormone receptor,proof-of-concept,p-based
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined